These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22184265)

  • 1. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease.
    Mahmoudi MJ; Hedayat M; Rezaei N; Saboor-Yaraghi AA; Mahmoudi M
    Iran J Allergy Asthma Immunol; 2011 Dec; 10(4):237-42. PubMed ID: 22184265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma soluble CD30 level correlates negatively with age in children.
    Chen JY; Fu LS; Chu JJ; Chen HC; Chi CS
    J Microbiol Immunol Infect; 2007 Apr; 40(2):168-72. PubMed ID: 17446967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.
    Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N
    J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
    Heshmat NM; El-Hadidi ES
    Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
    Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
    J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.
    Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G
    Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis.
    Jafari-Shakib R; Shokrgozar MA; Nassiri-Kashani M; Malakafzali B; Nikbin B; Khamesipour A
    Acta Trop; 2009 Jan; 109(1):61-3. PubMed ID: 18983807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
    Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo modulation of RANTES and sCD30 by proinflammatory stimuli in HIV-seropositive and -negative individuals.
    Delfanti F; Veglia F; Poli G; Lazzarin A; Biswas P
    Clin Immunol; 2000 Nov; 97(2):102-8. PubMed ID: 11027450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
    Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigen-stimulated induction and release of CD30 in patients with end-stage renal failure.
    Velásquez SY; Süsal C; Opelz G; García LF; Alvarez CM
    Hum Immunol; 2012 Nov; 73(11):1102-8. PubMed ID: 22940451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.
    Haque T; Chaggar T; Schafers J; Atkinson C; McAulay KA; Crawford DH
    J Med Virol; 2011 Feb; 83(2):311-6. PubMed ID: 21181928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients.
    Delezuch W; Marttinen P; Kokki H; Heikkinen M; Vanamo K; Pulkki K; Matinlauri I
    Tissue Antigens; 2012 Oct; 80(4):368-75. PubMed ID: 22861386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantation.
    Hübel K; Cremer B; Heuser E; von Strandmann EP; Hallek M; Hansen HP
    Transpl Immunol; 2010 Aug; 23(4):215-9. PubMed ID: 20620210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis.
    Ajdary S; Jafari-Shakib R; Riazi-Rad F; Khamesipour A
    J Infect; 2007 Jul; 55(1):75-8. PubMed ID: 17241668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of soluble CD30 in liver transplantation.
    Fábrega E; Unzueta MG; Cobo M; Casafont F; Amado JA; Romero FP
    Transplant Proc; 2007 Sep; 39(7):2295-6. PubMed ID: 17889168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30 ligand in lymphoma patients with CD30+ tumors.
    Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
    J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.
    Bauwens AM; van de Graaf EA; van Ginkel WG; van Kessel DA; Otten HG
    J Heart Lung Transplant; 2006 Apr; 25(4):416-9. PubMed ID: 16563971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.